OTC · PHCG
Pure Harvest Corporate Group, Inc.
$0.02-$0.00 (-6.84%)
Pure Harvest Corporate Group, Inc.’s quoted price sits in the lower half of its reported 52-week range, 80.13% below the high.
Loading market information…
OTC · EMMA · USD
Stock price, earnings
Quote as of Oct 29, 2026, 08:00 PM UTC. Cached market data; not a live quote.
One-year closing-price history · USD. Historical prices are not a forecast.
Emmaus Life Sciences, Inc.’s quoted price sits in the lower half of its reported 52-week range, 59.95% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
BEHIND THE RESULTS
Emmaus Life Sciences, Inc.’s next earnings report is currently expected on Nov 18, 2026, with estimated earnings per share of -$0.06. The reporting date and estimates may change.
Upcoming dates and analyst estimates may change. Fiscal quarters follow Emmaus Life Sciences, Inc.’s reporting calendar.
THE COMPANY BEHIND THE TICKER
Emmaus Life Sciences, Inc. is a commercial-stage biopharmaceutical enterprise dedicated to the discovery, development, commercialization, and sale of treatments and therapies, primarily addressing rare and orphan diseases across the United States and internationally. The company's flagship product is Endari, an L-glutamine oral powder designed to mitigate the acute complications associated with sickle cell disease in patients aged five and above, covering both pediatric and adult populations. Furthermore, Emmaus maintains a collaborative arrangement with Kainos Medicine, Inc. for the preclinical advancement of Kainos' proprietary IRAK4 inhibitor, KM10544, which is being explored as a potential anti-cancer therapeutic. Established in 2000 as Emmaus Holdings, Inc., the organization rebranded to Emmaus Life Sciences, Inc. in September 2011 and operates from its headquarters in Torrance, California.
Latest available per-share figures in USD. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 03:34 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
| -$0.04 |
| $2.41M |
| Q1 2025 | Apr 14, 2025 | $0.04+33.33% vs estimate | $7.07M+41.34% vs estimate |
|---|
| Q3 2024 | Nov 19, 2024 | -$0.01-200.0% vs estimate | $5.48M+9.56% vs estimate |
|---|
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
$0.02-$0.00 (-6.84%)
Pure Harvest Corporate Group, Inc.’s quoted price sits in the lower half of its reported 52-week range, 80.13% below the high.
$3.29$0.00 (0.0%)
Helix BioMedix, Inc.’s quoted price sits in the lower half of its reported 52-week range, 49.38% below the high.
$0.00$0.00 (0.0%)
Nutra Pharma Corp.’s quoted price sits in the lower half of its reported 52-week range, 98.0% below the high.
$0.02$0.00 (0.0%)
SQZ Biotechnologies Company’s quoted price sits in the lower half of its reported 52-week range, 65.71% below the high.
$0.00$0.00 (0.0%)
NeutriSci International Inc.: Healthcare · Drug Manufacturers - Specialty & Generic.
$0.05$0.00 (0.0%)
Orgenesis Inc.’s quoted price sits in the lower half of its reported 52-week range, 94.87% below the high.
$0.36$0.00 (0.0%)
Vibe Growth Corporation’s quoted price sits in the upper half of its reported 52-week range, 28.82% below the high.
$0.00$0.00 (0.0%)
Viropro Inc.’s quoted price sits in the lower half of its reported 52-week range, 80.0% below the high.
